Table 3: Relationship
between Bax mRNA expression levels and EGF doses in
the groups.
|
Group |
EGF |
Expression Value (2-∆∆CT) |
25% |
75% |
Pa |
|
C |
0 |
1.00 |
0.53 |
7.92 |
0.649 |
|
1 |
1.85 |
0.77 |
10.77 |
||
|
2 |
7.31 |
1.97 |
13.43 |
||
|
3 |
1.73 |
0.67 |
9.38 |
||
|
GU |
0 |
6.79 |
0.47 |
25.20 |
0.673 |
|
1 |
1.91 |
0.07 |
13.79 |
||
|
2 |
1.00 |
0.86 |
3.16 |
||
|
3 |
1.83 |
0.10 |
4.18 |
||
|
DU |
0 |
0.51 |
0.09 |
1.24 |
0.412 |
|
1 |
1.00 |
0.12 |
3.16 |
||
|
2 |
1.02 |
0.08 |
6.66 |
||
|
3 |
0.33 |
0.14 |
1.08 |
||
|
N87 |
0 |
1.78 |
0.71 |
5.71 |
0.402 |
|
1 |
1.20 |
0.30 |
1.52 |
||
|
2 |
0.79 |
0.38 |
1.11 |
||
|
3 |
0.91 |
0.36 |
7.76 |
||
|
Pb |
0 |
0.051 |
|
||
|
1 |
0.630 |
||||
|
2 |
0.199 |
||||
|
3 |
0.115 |
||||
C: Control,
GU: Gastric Ulcer, DU: Duodenal Ulcer, N87: Gastric cancer cell line, Pa:
The comparison between EGF doses of expression values for each group, Pb: The comparison between
the groups of expression values for each EGF dose (0: Kontrol;
1: 20 ng/µl EGF; 2: 50 ng/µl EGF; 3: 100 ng/µl EGF).